Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 23.8M | 23.3M | 24.1M | 45.3M |
Selling general and admin | 11.1M | 12.3M | 11.3M | 13.8M |
Other operating expenses | — | — | — | — |
Operating income | -35.0M | -35.7M | -35.4M | -59.2M |
Non operating interest income | ||||
Income | 1.1M | 2.3M | 2.3M | 3.2M |
Expense | 3.7M | 3.2M | 4.1M | 9.2M |
Other income expense | — | — | — | — |
Pretax income | -37.6M | -36.5M | -37.1M | -65.1M |
Tax provision | — | — | — | — |
Net income | -33.5M | -31.4M | -32.2M | -56.0M |
Basic EPS | -0.6 | -0.5 | -0.6 | -1.0 |
Diluted EPS | -0.6 | -0.5 | -0.6 | -1.0 |
Basic average shares | 58.1M | 58.0M | 57.9M | 57.9M |
Diluted average shares | 58.1M | 58.0M | 57.9M | 57.9M |
EBITDA | -33.6M | -33.1M | -32.8M | -55.7M |
Net income from continuing op. | -33.5M | -31.4M | -32.2M | -56.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |